DSM announces results of Annual General Meeting of Shareholders

DSM announces results of Annual General Meeting of Shareholders 
HEERLEN, NETHERLANDS -- (Marketwired) -- 05/03/13 --  
Royal DSM today held its Annual General Meeting of Shareholders. 
The following items were approved: 

  * Adoption of the Financial Statements for 2012
  * Adoption of the dividend for 2012 (see also separate press release)
  * Release from liability of the members of the Managing Board and
    Supervisory Board for their responsibilities in the financial year 2012
  * Appointment of Mr. D. de Vreeze as a member of the Managing Board
  * Reappointment of Mr. P. Hochuli as a member of the Supervisory Board
  * Adjustment of the remuneration policy for the Managing Board
  * Extension of the period during which the Managing Board is authorized
    to issue ordinary shares and to limit or exclude the preferential right
    when issuing ordinary shares
  * Authorization of the Managing Board to have the company repurchase
  * Reduction of the issued capital by canceling shares

DSM - Bright Science. Brighter Living.(TM) 
Royal DSM is a global science-based company active in health,
nutrition and materials. By connecting its unique competences in Life
Sciences and Materials Sciences DSM is driving economic prosperity,
environmental progress and social advances to create sustainable value
for all stakeholders. DSM delivers innovative solutions that nourish,
protect and improve performance in global markets such as food and
dietary supplements, personal care, feed, pharmaceuticals, medical
devices, automotive, paints, electrical and electronics, life
protection, alternative energy and bio- based materials. DSM's 23,500
employees deliver annual net sales of around EUR9 billion. The
company is listed on NYSE Euronext. More information can be found at
Press release-pdf: http://hugin.info/130663/R/1699046/560338.pdf 
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and    
other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and     
originality of the information contained therein. 
Source: DSM N.V.  via Thomson Reuters ONE 
For more information:
DSM Corporate Communications
Herman Betten
tel. +31 (0) 45 5782017
e-mail media.relations@dsm.com 
DSM Investor Relations
Dave Huizing
tel. +31 (0) 45 5782864
fax +31 (0) 10 4590275
e-mail investor.relations@dsm.com
Press spacebar to pause and continue. Press esc to stop.